Market Matters: December 31, 2021
Risk assets surged in fourth quarter, capping off a year of impressive gains.
Real Assets
Outlook 2022: Flying at a Lower Altitude
A compilation of our investment views for 2022.
Many Real Estate Assets Will Be Boosted by Secular Tailwinds
We believe a healthy macro backdrop and strong demand for inflation-sensitive assets will support most real estate assets in 2022. However, given stretched valuations for many core assets and COVID-19–related uncertainty around some sectors, we think return prospects are highest for assets that benefit from secular trends, such as the growing demand for healthcare and broadband.
Allocations to 21st-Century Infrastructure Increase
The infrastructure market has evolved since the financial crisis. Almost a majority of current investing is now in “21st-century infrastructure,” which includes digital and renewable assets. Given the expected importance of both sectors to future growth, we anticipate that investors will commit greater amounts of capital to each in 2022.
Market Matters: November 30, 2021
Risk assets sold off in November as pandemic-related developments introduced new uncertainties to the economic outlook.
Market Matters: October 31, 2021
Global equities delivered their highest monthly gains this year in October, driven by US equities.
US Manager Universe Statistics: Third Quarter 2021
This publication presents manager performance for 37 asset classes and substrategies, showing the median, mean, and key percentiles of return. Relevant indexes for each asset class are also included to provide market context.
Market Matters: September 2021
Capital markets performance was mixed in third quarter, with muted gains or losses across many asset classes.
Market Matters: August 2021
Risk-on sentiment returned in August as the global economic recovery continued, albeit at a slowing pace.
Review of Market Performance: Fiscal Year 2021
Fiscal year 2021 saw a continuation of the strong rebound in risk assets, which had commenced in second quarter 2020. This was facilitated initially by positive news from COVID-19 vaccine trials, and then ultimately by their gradual rollout, which established a path back toward economic normality. Meanwhile, both fiscal and monetary policy remained at extremely accommodative settings.